Why Cowboys’ Dak Prescott among NFL’s most overrated QBs, plus what to expect from Steelers’ new-look offense - CBS Sports ...

Although fewer companies fly the skyward tow ads, those who do claim business is booming and data backs them up.

Culhane’s Steak House doesn’t look like much from the outside, but inside those stone walls awaits a filet mignon experience ...

Isabella Perez-Murillo was one of less than one percent of applicants who win a full scholarship for undergraduate and ...

Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.3 billion in its U.S. initial public offering, as the market for new listings rebounds.

Other types of life sciences companies have begun to integrate AI and robotics to automate even the more mundane tasks. That ...

AmorSui, a sustainable personal protective equipment (PPE) company founded in Philadelphia by Beau Wangtrakuldee in 2018, was created to solve several problems with PPE, not least of which is the fact ...

Shares of Sai Life Sciences were flat on Friday, June 20, as private equity firm TPG Asia likely divested a significant portion of its stake in the firm through the block deal route. Around 2.08 ...

Caris Life Sciences Inc., a health-care company that uses technology to help diagnose and treat cancer, is seeking to raise $423.5 million in an initial public offering. The Sixth Street Partners ...

Caris Life Sciences bumped up the pricing of its IPO to raise more than $494.1 million in its Nasdaq debut—well over the range it first proposed last week, in the vicinity of $400 million.

Caris Life Sciences Media: Corporate Communications CorpComm@CarisLS.com 214.294.5606 Investor Relations: Narendra Chokshi Senior Vice President, Corporate Development nchokshi@CarisLS.com 917.689 ...

About This EventCaris Life Sciences (Nasdaq: CAI), a leading next-generation AI TechBio company and precision medicine pioneer, visits the Nasdaq MarketSite in Times Square.In honor of the ...